U.S. Supreme Court to review lawsuits over flaws in generic drugs
The court agreed to review a bid by Mutual Pharmaceutical Co to overturn a $21 million jury award to Karen Bartlett, a New Hampshire woman who had taken its generic non-steroidal anti-inflammatory drug sulindac for shoulder pain.
LATEST NEW HAMPSHIRE ANGLE
The accidental lobster farmers
Unions endorse pipeline through NH